Tag archief: English Only

Arch Re to Acquire Global Credit & Surety Renewal Rights From Aspen Re

Key personnel to join Arch as part of mutual agreement ZURICH–(BUSINESS WIRE)– Arch Reinsurance (Arch Re), a wholly owned subsidiary of Arch Capital Group Ltd....

Speech Processing Solutions: Philips Named One of the Top 3 Dictation & Transcription Services by Canadian Lawyers

TORONTO–(BUSINESS WIRE)– Philips Dictation, by Speech Processing Solutions, is the market leader in professional dictation and has been named a preferred supplier of dictation and...

Industry Veterans Appointed to Head the Global Technical Operations and Clinical Development Organizations at Kite

— Charles Calderaro and Ken Takeshita, MD to Join Kite’s Leadership Team — SANTA MONICA, Calif.–(BUSINESS WIRE)– Kite, a Gilead Company (Nasdaq: GILD), today announced...

FUNET builds 400G-ready network on ADVA FSP 3000 open line system

ROADM technology and ALM fiber monitoring solution ensure reliable, high-capacity connectivity across Finland HELSINKI–(BUSINESS WIRE)– ADVA (FSE: ADV) today announced that CSC – IT Center...

Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock

PARIS–(BUSINESS WIRE)– Inotrem S.A., a biotechnology company specializing in immunotherapy for acute inflammatory syndromes, through its knowledge of the TREM-1 pathway biology, announced today it...

Dawex Data Exchange Technology Brings Sustainable Future to Open Data

Integrating open data management capabilities to add governance, security and traceability layers to data sharing PARIS–(BUSINESS WIRE)– Dawex, the leading data exchange technology company and...

French Authorities Approve National Reimbursement of ORKAMBI (lumacaftor/ivacaftor) for Eligible People Ages Two and Older With Cystic Fibrosis

LONDON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the French Authorities (Comité économique des produits de santé, or CEPS) have approved national reimbursement...

Alibaba Group Announces Pricing of Global Offering

HANGZHOU, China–(BUSINESS WIRE)– Alibaba Group Holding Limited (NYSE: BABA) (“Alibaba” or the “Company”) today announced the pricing of the Global Offering of 500,000,000 ordinary shares...

Alibaba Cloud Powered $1B of GMV in 68 Seconds, with Zero Downtime During 11.11

Cloud infrastructure, AI-enabled tech underpinned $38B GMV in 24-hour global shopping spree HANGZHOU, China–(BUSINESS WIRE)– Alibaba Cloud today detailed the core technologies used during the...

ADVA and PSNC showcase 1200G channel transmission at SC19

FSP 3000 TeraFlex™ terminal delivers unprecedented spectral efficiency and client port flexibility for ultra-high-speed transmission DENVER–(BUSINESS WIRE)– ADVA (FSE: ADV) today announced that it’s hosting...

Positive Pivotal Data for Daiichi Sankyo’s DS-8201 ([Fam]-Trastuzumab Deruxtecan) in Patients with HER2 Positive Metastatic Breast Cancer to be Presented at SABCS

Objective response rate, progression-free survival, duration of response and safety data from DS-8201 pivotal study in HER2 positive metastatic breast cancer (DESTINY-Breast01) to be unveiled...

conova deploys ADVA OLS solution for highly secure DCI connectivity

ADVA FSP 3000 with ALM monitoring technology and Layer 1 encryption protects high-capacity Fibre Channel services SALZBURG, Austria–(BUSINESS WIRE)– ADVA (FSE: ADV) today announced that...

ADVA takes network slicing to next level in MEF19 5G PoC

Extensive partner ecosystem interoperates in ultra-low-latency edge compute network LOS ANGELES–(BUSINESS WIRE)– ADVA (FSE: ADV) today announced that it’s hosting a joint demo at MEF19,...

DaraPay Announces Strategic Partnership with Chinese Tech Giant- Alipay

PHNOM PENH, Cambodia–(BUSINESS WIRE)– DaraPay, the leading mobile E-wallet and payment service providers, today announces its partnership with Alipay, world’s leading payment and lifestyle platform...

Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists

This analysis on effectiveness also shows empagliflozin was associated with a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors or GLP-1 receptor...